Showing 1 - 3 results of 3 for search 'Handelsman Y', query time: 0.02s Refine Results
  1. 1
    Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

    Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects by Duprez DA, Handelsman Y, Koren M

    Published 2020-10-01
    Get full text
    Article
  2. 2
    Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study

    Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions... by Tomaszewski KJ, Allen A, Mocarski M, Schiffman A, Kruger D, Handelsman Y, Heile M, Brod M

    Published 2019-05-01
    Get full text
    Article
  3. 3
    Long-term efficacy of evolocumab in reducing lipids in EU subjects with and without type 2 diabetes: an analysis from the open-label extension OSLER studies

    Long-term efficacy of evolocumab in reducing lipids in EU subjects with and without type 2 diabetes: an analysis from the open-label extension OSLER studies by Sattar, N, Valensi, P, Preiss, D, Dent, R, Bridges, I, Ruzza, A, Cyrille, M, Handelsman, Y

    Published 2016
    Conference item

Search Tools: